Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system.

Cancer science - 1 Oct 2020

Hayashi Hideyuki, Tanishima Shigeki, Fujii Kyoko, Mori Ryo, Okada Chihiro, Yanagita Emmy, Shibata Yuka, Matsuoka Ryosuke, Amano Toraji, Yamada Takahiro, Yabe Ichiro, Kinoshita Ichiro, Komatsu Yoshito, Dosaka-Akita Hirotoshi, Nishihara Hiroshi

Abstract excerpt

Precision medicine is a promising strategy for cancer treatment. In this study, we developed an in-house clinical sequencing system to perform a comprehensive cancer genomic profiling test as a clinical examination and analyzed the utility of this system. Genomic DNA was extracted from tumor tissues and peripheral blood cells collected from 161 patients with different stages and types of cancer. A comprehensive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Class I Phosphatidylinositol 3-Kinases
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Precision Medicine

Share to Receptor, ErbB-2

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 32772458
DOI: 10.1111/cas.14608
PMCID: PMC7540994

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system.PMID 32772458Read ↗

Clinical Tumor Sequencing: Opportunities and Challenges for Precision Cancer MedicineSemantic proximity Read ↗

A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancers.Semantic proximity Read ↗

Personalized genomic analyses for cancer mutation discovery and interpretation.Semantic proximity Read ↗

A targeted next-generation sequencing panel for identification of clinically relevant mutation profiles in solid tumoursSemantic proximity Read ↗

Targeted therapy according to next generation sequencing-based panel sequencingSemantic proximity Read ↗

On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients.Semantic proximity Read ↗

Validation of a targeted sequencing panel with automatic analysis system for clinical decision support in cancer therapySemantic proximity Read ↗

Clinical application of tumour whole genome sequencing in routine molecular diagnostics for solid cancer patientsSemantic proximity Read ↗

Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.Semantic proximity Read ↗

High-throughput detection of clinically targetable alterations using next-generation sequencing.Semantic proximity Read ↗

Clinical Application of a Cancer Genomic Profiling Assay to Guide Precision Medicine DecisionsSemantic proximity Read ↗

Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing PanelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.